Observation of a Dose–Control Relationship for Lung and Liver Tumors After Stereotactic Body Radiation Therapy
- 1 January 2009
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 73 (1) , 112-118
- https://doi.org/10.1016/j.ijrobp.2008.03.062
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Steep Dose–Response Relationship for Stage I Non–Small-Cell Lung Cancer Using Hypofractionated High-Dose Irradiation by Real-Time Tumor-Tracking RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2008
- The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung CancerJournal of Thoracic Oncology, 2007
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung CancerJournal of Clinical Oncology, 2006
- The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumorsJournal of Applied Clinical Medical Physics, 2006
- Interim analysis of a prospective phase I/II trial of SBRT for liver metastasesActa Oncologica, 2006
- Stereotactic body radiation therapy for centrally located lung lesionsActa Oncologica, 2006
- Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frameInternational Journal of Radiation Oncology*Biology*Physics, 2005
- A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastasesInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targetsInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Reporting and analyzing dose distributions: A concept of equivalent uniform doseMedical Physics, 1997